EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and molecular characterization of patients with YWHAG ‐related epilepsy

Valentina Cetica iD, Tiziana Pisano iD, Gaetan Lesca iD, Dana Marafi, Laura Licchetta iD, Florence Riccardi, Davide Mei iD, Hon-Yin B Chung, Allan Bayat iD, Meena Balasubramanian, Daniel H Lowenstein, Milda Endzinienė und 23 weitere

Epilepsia · 2024

DOI: 10.1111/epi.17939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Valentina Cetica und 34 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Department, Meyer Children's Hospital IRCCS, Florence, Italy. Hauptthemen laut MEDLINE: Epilepsy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Medical Research Council, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

YWHAG variant alleles have been associated with a rare disease trait whose clinical synopsis includes an early onset epileptic encephalopathy with predominantly myoclonic seizures, developmental delay/intellectual disability, and facial dysmorphisms. Through description of a large cohort, which doubles the number of reported patients, we further delineate the spectrum of YWHAG ‐related epilepsy.

Methods

We included in this study 24 patients, 21 new and three previously described, with pathogenic/likely pathogenic variants in YWHAG . We extended the analysis of clinical, electroencephalographic, brain magnetic resonance imaging, and molecular genetic information to 24 previously published patients.

Results

The phenotypic spectrum of YWHAG ‐related disorders ranges from mild developmental delay to developmental and epileptic encephalopathy (DEE). Epilepsy onset is in the first 2 years of life. Seizure freedom can be achieved in half of the patients (13/24, 54%). Intellectual disability (23/24, 96%), behavioral disorders (18/24, 75%), neurological signs (13/24, 54%), and dysmorphisms (6/24, 25%) are common. A genotype–phenotype correlation emerged, as DEE is more represented in patients with missense variants located in the ligand‐binding domain than in those with truncating or missense variants in other domains (90% vs. 19%, p < .001). Significance This study suggests that pathogenic YWHAG variants cause a wide range of clinical presentations with variable severity, ranging from mild developmental delay to DEE. In this allelic series, a genotype–phenotype correlation begins to emerge, potentially providing prognostic information for clinical management and genetic counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyAdolescentAdultChildChild, PreschoolFemaleHumansInfantMaleYoung AdultCohort StudiesDevelopmental DisabilitiesElectroencephalographyGenetic Association StudiesIntellectual DisabilityMagnetic Resonance ImagingPhenotype

Stichwörter der Autor:innen

YWHAGepilepsygenotype–phenotype correlation

Autor:innen und Institutionen

  • Neuroscience Department, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Université Lyon 1, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Physiopathologie et Génétique du Neurone et du Muscle, Institut NeuroMyoGène, L…
  • Department of Genetics, University Hospitals of Lyon, Hospices Civils de Lyon, Lyon, France.
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Pediatrics, Faculty of Medicine, Kuwait University, Safat, Kuwait.
  • Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, Istituto delle Scienze Neurologiche di Bologna, full member of the European Reference Network EpiCARE, Bologna, Italy.

ORCID-Profile: Valentina Cetica, Tiziana Pisano, Gaetan Lesca, Laura Licchetta, Davide Mei, Allan Bayat, Roberta Solazzi, Julien Jung, Francesca Bisulli, Renzo Guerrini

Förderung

  • NIH HHS
  • Medical Research Council
  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Agenzia Italiana del Farmaco, Ministero della Salute
  • National Human Genome Research Institute
  • Fondazione Cassa di Risparmio di Firenze
  • Regione Toscana

Zitieren

APA

Cetica, V., Pisano, T., Lesca, G., Marafi, D., Licchetta, L., Riccardi, F., Mei, D., Chung, H. B., Bayat, A., Balasubramanian, M., Lowenstein, D. H., Endzinienė, M., Alotaibi, M., Villeneuve, N., Jacobs, J., Isidor, B., Solazzi, R., den Hollander, N. S., Marjanovic, D., …, & YWHAG Study Group (2024). Clinical and molecular characterization of patients with YWHAG ‐related epilepsy. Epilepsia. https://doi.org/10.1111/epi.17939

Vancouver

Cetica V, Pisano T, Lesca G, Marafi D, Licchetta L, Riccardi F, et al. Clinical and molecular characterization of patients with YWHAG ‐related epilepsy. Epilepsia. 2024. doi:10.1111/epi.17939

BibTeX
@article{Cetica2024,
  author = {Cetica, Valentina and Pisano, Tiziana and Lesca, Gaetan and Marafi, Dana and Licchetta, Laura and Riccardi, Florence and Mei, Davide and Chung, Hon-Yin B and Bayat, Allan and Balasubramanian, Meena and Lowenstein, Daniel H and Endzinienė, Milda and Alotaibi, Maha and Villeneuve, Nathalie and Jacobs, Julia and Isidor, Bertrand and Solazzi, Roberta and den Hollander, Nicolette S and Marjanovic, Dragan and Rougeot-Jung, Christelle and Jung, Julien and Lesieur-Sebellin, Marion and Accogli, Andrea and Salpietro, Vincenzo and Saadi, Nebal W and Panagiotakaki, Eleni and Foiadelli, Thomas and Redon, Sylvia and Tsai, Meng-Han and Bisulli, Francesca and Hammer, Trine B and Lupski, James R and Parrini, Elena and Guerrini, Renzo and YWHAG Study Group, YWHAG Study Group},
  title = {Clinical and molecular characterization of patients with YWHAG ‐related epilepsy},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.17939}
}
Kostenlos starten →